Payment overview · 2025
General Payments
$61.14
1 reported records · 1 companies
Healthcare provider profile · identity verified
Carlos A Silva, MD
Allopathic & Osteopathic Physicians|Internal Medicine · TAMPA, FL · NPI 1275577694
Verified facts
What the public records show
CMS Open Payments records show Carlos A Silva, MD received $61.14 in general payments during 2025 across 1 reported records.
Johnson & Johnson Health Care Systems Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Johnson & Johnson Health Care Systems Inc. | Unresolved — no canonical attribution shown | $61.14 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $61.14 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CARVYKTI Normalized: carvykti |
Drug | Johnson & Johnson Health Care Systems Inc. | $61.14 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 861 | 248 |
| Levothyroxine Sodium | Levothyroxine Sodium | 514 | 139 |
| Amlodipine Besylate | Amlodipine Besylate | 440 | 131 |
| Losartan Potassium | Losartan Potassium | 423 | 118 |
| Omeprazole | Omeprazole | 385 | 109 |
| Metformin Hcl | Metformin Hcl | 353 | 104 |
| Gabapentin | Gabapentin | 330 | 101 |
| Lisinopril | Lisinopril | 308 | 93 |
| Pantoprazole Sodium | Pantoprazole Sodium | 278 | 75 |
| Hydrochlorothiazide | Hydrochlorothiazide | 260 | 83 |
| Montelukast Sodium | Montelukast Sodium | 254 | 66 |
| Escitalopram Oxalate | Escitalopram Oxalate | 253 | 67 |
| Metoprolol Tartrate | Metoprolol Tartrate | 253 | 71 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 224 | 69 |
| Meloxicam | Meloxicam | 215 | 58 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 215 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 206 | 57 |
| Furosemide | Furosemide | 196 | 60 |
| Fluticasone Propionate | Fluticasone Propionate | 192 | 66 |
| Prednisone | Prednisone | 185 | 80 |
| Baclofen | Baclofen | 183 | 61 |
| Trazodone Hcl | Trazodone Hcl | 180 | 47 |
| Alprazolam | Alprazolam | 177 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 158 | 44 |
| Tramadol Hcl | Tramadol Hcl | 155 | 47 |
| Azithromycin | Azithromycin | 142 | 110 |
| Celecoxib | Celecoxib | 138 | 44 |
| Glimepiride | Glimepiride | 132 | 37 |
| Potassium Chloride | Potassium Chloride | 129 | 47 |
| Eliquis | Apixaban | 126 | 26 |
| Glipizide | Glipizide | 111 | 34 |
| Allopurinol | Allopurinol | 104 | 31 |
| Carvedilol | Carvedilol | 99 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 99 | 28 |
| Fenofibrate | Fenofibrate | 96 | 24 |
| Simvastatin | Simvastatin | 92 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 26 |
| Finasteride | Finasteride | 85 | 25 |
| Ezetimibe | Ezetimibe | 84 | 26 |
| Famotidine | Famotidine | 80 | 24 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 80 | suppressed |
| Sucralfate | Sucralfate | 68 | 25 |
| Alendronate Sodium | Alendronate Sodium | 67 | 19 |
| Donepezil Hcl | Donepezil Hcl | 66 | 15 |
| Clonidine Hcl | Clonidine Hcl | 65 | 16 |
| Meclizine Hcl | Meclizine Hcl | 64 | 30 |
| Temazepam | Temazepam | 63 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 62 | 17 |
| Sertraline Hcl | Sertraline Hcl | 62 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 60 | 17 |
| Lorazepam | Lorazepam | 59 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 58 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 58 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 56 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 51 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 51 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 50 | 42 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 50 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 46 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 46 | 12 |
| Cephalexin | Cephalexin | 44 | 27 |
| Mirtazapine | Mirtazapine | 44 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 43 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 43 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 43 | 21 |
| Oxybutynin Chloride | Oxybutynin Chloride | 42 | suppressed |
| Naproxen | Naproxen | 41 | 11 |
| Lovastatin | Lovastatin | 40 | 12 |
| Xarelto | Rivaroxaban | 39 | suppressed |
| Clonazepam | Clonazepam | 38 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 37 | suppressed |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 34 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 34 | suppressed |
| Atenolol | Atenolol | 33 | 11 |
| Metformin Hcl Er | Metformin Hcl | 33 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 31 | 11 |
| Calcitriol | Calcitriol | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 16 |
| Memantine Hcl | Memantine Hcl | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 20 |
| Topiramate | Topiramate | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 27 | suppressed |
| Valsartan | Valsartan | 26 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 23 | suppressed |
| Metolazone | Metolazone | 23 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Acarbose | Acarbose | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 22 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 21 | suppressed |
| Cefdinir | Cefdinir | 21 | 19 |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 12 |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 19 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 19 | suppressed |
| Ibu | Ibuprofen | 19 | suppressed |
| Mupirocin | Mupirocin | 19 | suppressed |
| Ozempic | Semaglutide | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Latanoprost | Latanoprost | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Spironolactone | Spironolactone | 18 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 17 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Klor-Con 10 | Potassium Chloride | 16 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Jardiance | Empagliflozin | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 14 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Oxycontin | Oxycodone Hcl | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $61.14 · 1 records | Johnson & Johnson Health Care Systems Inc. | CARVYKTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error